Greenlight Guru Acquires Electronic Data Capture Solution SMART-TRIAL

(Greenlight Guru: Indianapolis, IN)--Greenlight Guru, pioneer of the Medtech Lifecycle Excellence Platform, has acquired SMART-TRIAL, maker of the first and only electronic data capture (EDC) platform designed for medical devices and diagnostics. SMART-TRIAL offers a comprehensive data collection toolbox to comply with regulatory requirements on clinical data.

Medtech clinical operations are different from other life-science industries. The SMART-TRIAL platform was designed with the sole purpose of addressing the exact challenges of the medical device and diagnostics industry. The platform has been fine-tuned in collaboration with manufacturers over the past nine years to ensure an ideal out-of-the-box fit with the clinical life cycle of devices.

With increasingly strict regulations for clinical data collection on medical devices, as well as challenges in automating and streamlining the clinical evidence process, the need for SMART-TRIAL’s industry-specific solution to reduce the workload and cost of clinical operations has never been greater.

Founded in 2013 by CEO Páll Jóhannesson, CCO Jón Ingi Bergsteinsson, and CTO Alex Bondo Andersen, the Denmark-based software company has helped more than 100 companies easily and effectively collect high-quality clinical data in compliance with industry regulations. The SMART-TRIAL platform has evolved into a market-leading complete data collection toolbox for clinical studies, clinical investigations, clinical performance studies, post-market clinical follow-up (PMCF), and post-market performance follow-up (PMPF).

With all three SMART-TRIAL founders and their team of more than 20 employees joining Greenlight Guru, its acquisition will enable the Indianapolis-based company to further expand its platform capabilities and enable medical technology companies to achieve true quality across all phases of the product life cycle.

“60 percent of Greenlight Guru clients are currently running a clinical trial or are expecting to run one in the next two years, and over half of those are still using paper or Excel to manage the data. That is not only costly but extremely risky, given the increasingly strict regulations on clinical data quality,” says Greenlight Guru CEO David DeRam. “Greenlight Guru and SMART-TRIAL have very similar missions and values, and we’re both exclusively focused on providing medtech companies with tailored software solutions to delightfully meet their needs. I know we can realize our shared goal much faster by combining forces.”

“Greenlight Guru’s vision for the future of medtech is exactly what the industry needs, and we are very happy to be part of what will become the golden standard software platform for medtech companies around the globe,” says SMART-TRIAL CEO Páll Jóhannesson. “With the combined experience of Greenlight Guru and SMART-TRIAL, and synergies between the platforms, we will be able to provide an offering for medtech of unprecedented quality and scale.”

First published June 2, 2022, on the Greenlight Guru blog.

About The Author